Ruth E Hogg, Sobha Sivaprasad, Robin Wickens, Sean O'Connor, Eleanor Gidman, Elizabeth Ward, Charlene Treanor, Tunde Peto, Ben J L Burton, Paul Knox, Andrew J Lotery, Michael Donnelly, Chris A Rogers, Barnaby C Reeves
IMPORTANCE: Most neovascular age-related macular degeneration (nAMD) treatments involve long-term follow-up of disease activity. Home-monitoring would reduce the burden on patients and their caregivers and release clinic capacity. OBJECTIVE: To evaluate 3 vision home-monitoring tests for patients to use to detect active nAMD compared with diagnosing active nAMD at hospital follow-up during the after-treatment monitoring phase. DESIGN, SETTING, AND PARTICIPANTS: This was a diagnostic test accuracy study wherein the reference standard was detection of active nAMD by an ophthalmologist at hospital follow-up...
April 25, 2024: JAMA Ophthalmology